Market Overview:
The global cystic fibrosis (mucoviscoidosis) testing market is expected to register a CAGR of 7.8% during the forecast period, 2018-2030. The growth in this market can be attributed to the increasing incidence of cystic fibrosis, rising awareness about early diagnosis and treatment options for cystic fibrosis, and technological advancements in diagnostic tests for cystic fibrosis. However, the high cost of diagnosis and treatment is likely to restrain the growth of this market during the forecast period. Based on type, the global cystic fibrosis (mucoviscoidosis) testing market can be segmented into chest physical therapy (CPT), consumption of antibiotics, lung transplantation surgery and postural drainage. Among these segments, chest physical therapy is expected to account for a major share of the global market during the forecast period owing to its ability to improve lung function in patients with CF. Consumption of antibiotics is also anticipated to grow at a significant rate duringthe forecast period due its abilityto reduce infection rates among CF patients.
Testing Industry Outlook.svg)
Product Definition:
Cystic fibrosis (CF) is a genetic disorder that affects the lungs and digestive system. CF causes the body to produce thick, sticky mucus that can clog the lungs and lead to difficulty breathing. The mucus also can block the pancreatic ducts, preventing digestive enzymes from reaching the small intestine and leading to malnutrition. CF occurs when both parents pass on a defective gene for CF to their child. Cystic Fibrosis(Mucoviscoidosis)Testing is important because it helps identify people who have or may develop cystic fibrosis.
Chest Physical Therapy (CPT):
Physical Therapy (PT) is a rehabilitation process that aims at restoring movement and function after an injury or surgery. Physical therapy includes the use of various techniques to improve lung capacity, strength, flexibility, agility & balance among other physical attributes. The treatment helps in reducing shortness of breath and improves overall fitness levels which are essential for fighting respiratory diseases such as cystic fibrosis(mucoviscoidosis).
Consumption Of Antibiotics:
Antibiotics are drugs used to destroy the bacteria. The term “antibiotic” is derived from Greek word “antibo” which means against or opposed to life or living force. Antibiotics can be classified into two types: first, those substances produced by microorganisms such as fungi and bacteria; second, chemicals manufactured by animals (e.g., penicillin).
Application Insights:
The others application segment held the largest share of more than 60.0% in 2017. The other applications include home healthcare and hospital based clinics, which are anticipated to witness significant growth over the forecast period due to rising awareness about cystic fibrosis among individuals and healthcare professionals, coupled with increasing government initiatives for early diagnosis.
Hospitals were estimated as the largest revenue generating centers owing to a large patient base suffering from chronic respiratory diseases caused by cystic fibrosis across various hospitals in North America and Europe. In addition, an increase in prevalence rates of this disease is expected to boost market growth over the forecast period as most patients remain undiagnosed resulting in high demand for diagnostic procedures performed at hospitals or accredited laboratories.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of key players, availability of advanced technologies and high disease prevalence in this region. The U.S., which is one of the most developed countries with a high standard of living, holds a major share in this regional market due to higher awareness levels about CF among people and rapid technological advancements pertaining to diagnosis methods & treatment options for CF patients.
Asia Pacific is expected to grow at an exponential rate during the forecast period owing to increasing government initiatives & funds for improving healthcare infrastructure coupled with rising awareness about cystic fibrosis among people especially parents that result into an increased number of cases over time as well as across generations thereby resulting into a greater need for testing products/services such as blood tests, diagnostic procedures, therapeutic drugs and other supportive therapies required by patients suffering from mucoviscidosis or cystic fibrosis thus driving growth across this region (revenue generated by country).
Growth Factors:
- Increasing incidence of cystic fibrosis: The global incidence of cystic fibrosis is estimated to be around 70,000 cases. This number is expected to grow in the coming years due to increasing awareness and improved diagnosis rates.
- Growing demand for novel therapies: There is a growing demand for novel therapies for cystic fibrosis as the current treatments are only partially effective. This has led to the development of several new drugs and therapies that are currently in clinical trials.
- Rising R&D investment by pharmaceutical companies: Pharmaceutical companies are investing heavily in R&D for new drugs and therapies for cystic fibrosis, as this is a high-potential market with unmet needs. This will lead to the development of more effective treatments in the future.
Scope Of The Report
Report Attributes
Report Details
Report Title
Cystic Fibrosis(Mucoviscoidosis)Testing Market Research Report
By Type
Chest Physical Therapy (CPT), Consumption Of Antibiotics, Lung Transplant And Postural Drainage
By Application
Hospitals, Ambulatory Surgical Centers, Others
By Companies
Vertex Pharmaceuticals, Abbott, Pfizer, NovaBiotics, Cystic Fibrosis Foundation, Galapagos
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
164
Number of Tables & Figures
115
Customization Available
Yes, the report can be customized as per your need.
Global Cystic Fibrosis(Mucoviscoidosis)Testing Market Report Segments:
The global Cystic Fibrosis(Mucoviscoidosis)Testing market is segmented on the basis of:
Types
Chest Physical Therapy (CPT), Consumption Of Antibiotics, Lung Transplant And Postural Drainage
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Ambulatory Surgical Centers, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Vertex Pharmaceuticals
- Abbott
- Pfizer
- NovaBiotics
- Cystic Fibrosis Foundation
- Galapagos
Testing Market Overview.svg)
Highlights of The Cystic Fibrosis(Mucoviscoidosis)Testing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Chest Physical Therapy (CPT)
- Consumption Of Antibiotics
- Lung Transplant And Postural Drainage
- By Application:
- Hospitals
- Ambulatory Surgical Centers
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Cystic Fibrosis(Mucoviscoidosis)Testing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
Testing Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Cystic Fibrosis testing is a procedure used to diagnose Cystic Fibrosis. This test uses samples of mucus from the lungs and throat to determine if the person has Cystic Fibrosis.
Some of the major players in the cystic fibrosis(mucoviscoidosis)testing market are Vertex Pharmaceuticals, Abbott, Pfizer, NovaBiotics, Cystic Fibrosis Foundation, Galapagos.
The cystic fibrosis(mucoviscoidosis)testing market is expected to register a CAGR of 7.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Cystic Fibrosis(Mucoviscoidosis)Testing Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Cystic Fibrosis(Mucoviscoidosis)Testing Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Cystic Fibrosis(Mucoviscoidosis)Testing Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Cystic Fibrosis(Mucoviscoidosis)Testing Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Cystic Fibrosis(Mucoviscoidosis)Testing Market Size & Forecast, 2018-2028
4.5.1 Cystic Fibrosis(Mucoviscoidosis)Testing Market Size and Y-o-Y Growth
4.5.2 Cystic Fibrosis(Mucoviscoidosis)Testing Market Absolute $ Opportunity
Chapter 5 Global Cystic Fibrosis(Mucoviscoidosis)Testing Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Cystic Fibrosis(Mucoviscoidosis)Testing Market Size Forecast by Type
5.2.1 Chest Physical Therapy (CPT)
5.2.2 Consumption Of Antibiotics
5.2.3 Lung Transplant And Postural Drainage
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Cystic Fibrosis(Mucoviscoidosis)Testing Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Cystic Fibrosis(Mucoviscoidosis)Testing Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Ambulatory Surgical Centers
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Cystic Fibrosis(Mucoviscoidosis)Testing Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Cystic Fibrosis(Mucoviscoidosis)Testing Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Cystic Fibrosis(Mucoviscoidosis)Testing Analysis and Forecast
9.1 Introduction
9.2 North America Cystic Fibrosis(Mucoviscoidosis)Testing Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Cystic Fibrosis(Mucoviscoidosis)Testing Market Size Forecast by Type
9.6.1 Chest Physical Therapy (CPT)
9.6.2 Consumption Of Antibiotics
9.6.3 Lung Transplant And Postural Drainage
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Cystic Fibrosis(Mucoviscoidosis)Testing Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Ambulatory Surgical Centers
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Cystic Fibrosis(Mucoviscoidosis)Testing Analysis and Forecast
10.1 Introduction
10.2 Europe Cystic Fibrosis(Mucoviscoidosis)Testing Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Cystic Fibrosis(Mucoviscoidosis)Testing Market Size Forecast by Type
10.6.1 Chest Physical Therapy (CPT)
10.6.2 Consumption Of Antibiotics
10.6.3 Lung Transplant And Postural Drainage
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Cystic Fibrosis(Mucoviscoidosis)Testing Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Ambulatory Surgical Centers
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Cystic Fibrosis(Mucoviscoidosis)Testing Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Cystic Fibrosis(Mucoviscoidosis)Testing Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Cystic Fibrosis(Mucoviscoidosis)Testing Market Size Forecast by Type
11.6.1 Chest Physical Therapy (CPT)
11.6.2 Consumption Of Antibiotics
11.6.3 Lung Transplant And Postural Drainage
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Cystic Fibrosis(Mucoviscoidosis)Testing Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Ambulatory Surgical Centers
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Cystic Fibrosis(Mucoviscoidosis)Testing Analysis and Forecast
12.1 Introduction
12.2 Latin America Cystic Fibrosis(Mucoviscoidosis)Testing Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Cystic Fibrosis(Mucoviscoidosis)Testing Market Size Forecast by Type
12.6.1 Chest Physical Therapy (CPT)
12.6.2 Consumption Of Antibiotics
12.6.3 Lung Transplant And Postural Drainage
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Cystic Fibrosis(Mucoviscoidosis)Testing Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Ambulatory Surgical Centers
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Cystic Fibrosis(Mucoviscoidosis)Testing Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Cystic Fibrosis(Mucoviscoidosis)Testing Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Cystic Fibrosis(Mucoviscoidosis)Testing Market Size Forecast by Type
13.6.1 Chest Physical Therapy (CPT)
13.6.2 Consumption Of Antibiotics
13.6.3 Lung Transplant And Postural Drainage
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Cystic Fibrosis(Mucoviscoidosis)Testing Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Ambulatory Surgical Centers
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Cystic Fibrosis(Mucoviscoidosis)Testing Market: Competitive Dashboard
14.2 Global Cystic Fibrosis(Mucoviscoidosis)Testing Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Vertex Pharmaceuticals
14.3.2 Abbott
14.3.3 Pfizer
14.3.4 NovaBiotics
14.3.5 Cystic Fibrosis Foundation
14.3.6 Galapagos
